D
Crinetics Pharmaceuticals, Inc. CRNX
$30.93 $0.842.79% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 1.03M 361.00K 0.00 -- 399.00K
Total Other Revenue -- -- -- -- --
Total Revenue 1.03M 361.00K 0.00 -- 399.00K
Cost of Revenue 13.10M 76.24M 66.57M 61.91M 11.49M
Gross Profit -12.07M -75.88M -66.57M -61.91M -11.09M
SG&A Expenses 49.84M 35.53M 28.18M 25.89M 24.84M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 130.14M 111.77M 94.75M 87.80M 83.18M
Operating Income -129.11M -111.41M -94.75M -87.80M -82.78M
Income Before Tax -115.64M -96.77M -80.60M -76.83M -74.06M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -115.64M -96.77M -80.60M -76.83M -74.06M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -115.64M -96.77M -80.60M -76.83M -74.06M
EBIT -129.11M -111.41M -94.75M -87.80M -82.78M
EBITDA -128.15M -110.48M -93.96M -87.03M -82.03M
EPS Basic -1.23 -1.04 -0.88 -0.96 -0.94
Normalized Basic EPS -0.77 -0.65 -0.55 -0.60 -0.59
EPS Diluted -1.23 -1.04 -0.88 -0.96 -0.94
Normalized Diluted EPS -0.77 -0.65 -0.55 -0.60 -0.59
Average Basic Shares Outstanding 93.79M 93.10M 91.49M 80.09M 79.01M
Average Diluted Shares Outstanding 93.79M 93.10M 91.49M 80.09M 79.01M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --